Quick Order

Text Size:AAA

MMP-2 / CLG4A Antibody, Rabbit PAb

DatasheetReviewsRelated ProductsProtocols
Human MMP-2 Antibody Product Information
Immunogen:Recombinant Human MMP-2 protein (Catalog#10082-HNAH)
Clone ID:
Ig Type:Rabbit IgG
Concentration:
Formulation:0.2 μm filtered solution in PBS with 5% trehalose
Preparation:Produced in rabbits immunized with purified, recombinant Human MMP2 (rh MMP-2; Catalog#10082-HNAH; NP_004521.1; Met 1-Cys 660). Total IgG was purified by Protein A affinity chromatography .
Human MMP-2 Antibody Usage Guide
Specificity:Human MMP-2 / CLG4A
Application:ELISA

ELISA: 0.5-1 μg/mL

This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect huan MMP-2. The detection limit for Human MMP-2 is 0.039 ng/well.

Storage:This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.
Other MMP-2 Antibody Products
Reactivity: Human  
Application: ELISA  WB  IP  
  • Slide 1
  • Slide 1
10082-RP02-200
10082-RP02-50
10082-RP02-100
200 µg 
50 µg 
100 µg 
Add to Cart
Reactivity: Human  
Application: WB  
  • Slide 1
10082-R026-100
10082-R026-50
100 µg 
50 µg 
Add to Cart
Reactivity: Human  
Application: ELISA  
    10082-R029-50
    10082-R029-100
    50 µg 
    100 µg 
    Add to Cart
    Reactivity: Human  
    Application: ELISA  WB  
    • Slide 1
    10082-MM05-200
    10082-MM05-50
    10082-MM05-100
    200 µg 
    50 µg 
    100 µg 
    Add to Cart
    Reactivity: Mouse  
    Application: ELISA  
      52740-RP01-400
      52740-RP01-200
      52740-RP01-100
       
      200 µg 
      100 µg 
      Add to Cart
      MMP2/MMP-2/CLG4A Background

      Matrix Metalloproteinase-2 (MMP-2) is an enzyme that degrades components of the extracellular matrix and thus plays a pivotal role in cell migration during physiological and pathological processes. MMP-2 expression is dependent on extracellular matrix metalloproteinase inducer (EMMPRIN), Her2/neu, growth factors, cytokines, and hormones. Pro-MMP-2 activation needs MT1-MMP and TIMP-2 contribution. MMP-2 is changed in distribution and increased in amount in the ventral cochlear nucleus after unilateral cochlear ablation. A low level of MMP-2 is linked to favorable prognosis in patients with a hormone receptor-negative tumor, usually associated with high risk. As a zymogen requiring proteolytic activation for catalytic activity, MMP-2 has been implicated broadly in the invasion and metastasis of many cancer model systems, including human breast cancer (HBC). Blocking MMP-2 secretion and activation during breast carcinoma development may decrease metastasis. The detection of active MMP-2 alone or the rate of pro-MMP-2 and active MMP-2 is considered a very sensitive indicator of cancer metastasis. Modulation of MMP-2 expression and activation through specific inhibitors and activators may thus provide a new mechanism for breast cancer treatment.

      Human MMP2/MMP-2/CLG4A References
    • Thompson EW, et al. (1994) Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Res Treat. 31(2-3): 357-70.
    • Jezierska A, et al. (2009) Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Monit. 15(2): RA32-40.
    • Fredrich M, et al. (2010) MMP-2 is involved in synaptic remodeling after cochlear lesion. Neuroreport. 21(5): 324-7.
    • Product nameProduct name
      All information of our products is subject to change without notice. Please refer to COA enclosed in shipped package for the newest information.
      Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"